Literature DB >> 31216904

Pharmacology mechanism of Flos magnoliae and Centipeda minima for treating allergic rhinitis based on pharmacology network.

Yulin Liang1, Xiaofei Zhang2, Junbo Zou2, Yajun Shi2, Yu Wang1, Jia Tai1, Yanjun Yang1, Xiao Zhou1, Dongyan Guo2, Jing Wang2, Jiangxue Cheng2, Ming Yang3.   

Abstract

Chinese herbs such as Flos magnoliae (FM) and Centipeda minima (CM) can be effective in treating allergic rhinitis (AR). However, there is little research on the therapeutic mechanism of these two drugs acting on AR at the same time. In order to systematically understand the mechanism of action of two drugs acting on AR at the same time, we searched various databases to obtain 31 components and 289 target proteins of FM, 25 components and 465 target proteins of CM. The interaction networks of FM, CM, and AR proteins were constructed by Cytoscape-v3.2.1 software. The core protein of two network intersections was obtained by using Venny 2.1.0. The R platform was used for the core target protein gene ontology (GO) comment analysis and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis. Thirteen common targets and seven acting pathways were obtained. The results of animal experiments showed that FM and CM volatile oil could effectively improve the symptoms of AR by regulating the common targets. In summary, this study successfully explained the potential therapeutic mechanism of FM and CM in the treatment of AR. At the same time, it indicates that the two drugs can be compatible as a new application.

Entities:  

Keywords:  allergic rhinitis; network pharmacology; pathway enrichment

Year:  2019        PMID: 31216904     DOI: 10.1080/03639045.2019.1635150

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  A network pharmacology study with molecular docking to investigate the possibility of licorice against posttraumatic stress disorder.

Authors:  Zhi-Kun Qiu; Zhi-Ting Liu; Jia-Li Pang; Han-Biao Wu; Xu Liu; Ze-Min Yang; Xiong Li; Ji-Sheng Chen
Journal:  Metab Brain Dis       Date:  2021-08-21       Impact factor: 3.584

2.  Magnoliae flos Downregulated Lipopolysaccharide-Induced Inflammatory Responses via NF-κB/ERK-JNK MAPK/STAT3 Pathways.

Authors:  Tae-Young Gil; Bo-Ram Jin; Yun-Yeop Cha; Hyo-Jin An
Journal:  Mediators Inflamm       Date:  2022-06-26       Impact factor: 4.529

3.  Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real-World Database.

Authors:  Yen-Chu Lu; Ching-Wei Yang; Yi-Hsuan Lin; Ju-Yu Hsueh; Jiun-Liang Chen; Sien-Hung Yang; Yu-Chun Chen; Hsing-Yu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-05       Impact factor: 2.629

4.  A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases.

Authors:  Chun Li; Xia Du; Yang Liu; Qi-Qi Liu; Wen Bing Zhi; Chun Liu Wang; Jie Zhou; Ye Li; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-08       Impact factor: 2.629

5.  Validated Impacts of N6-Methyladenosine Methylated mRNAs on Apoptosis and Angiogenesis in Myocardial Infarction Based on MeRIP-Seq Analysis.

Authors:  Yingjie Zhang; Wenjie Hua; Yini Dang; Yihui Cheng; Jiayue Wang; Xiu Zhang; Meiling Teng; Shenrui Wang; Min Zhang; Zihao Kong; Xiao Lu; Yu Zheng
Journal:  Front Mol Biosci       Date:  2022-01-28

6.  Preparation and quality evaluation of a volatile oil microemulsion from Flos magnoliae and Centipeda minima.

Authors:  Yulin Liang; Junbo Zou; Xiaofei Zhang; Yajun Shi; Jia Tai; Yu Wang; Dongyan Guo; Ming Yang
Journal:  Mol Med Rep       Date:  2020-10-08       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.